PharmaShots | Incisive News in 3 Shots

Subscribe Now

Advanced or Metastatic RET-Mutant

Roche's Gavreto (pralsetinib) Receives the US FDA's Approval for Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancers

Roche's Gavreto (pralsetinib) Receives the US FDA's Approval for Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid...

December 2, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us